Influence of insulin resistance and ribavirin dosage in viral dynamics of patients with chronic hepatitis C genotype 1 treated with peginterferon and ribavirin

被引：3
|
作者：
Grande, L.
Madrazo, A.
Viloria, M. M.
Nogales, M. C.
Corpas, R.
Camacho, I.
Sanchez-Munoz, D.
Martin-Mazuelos, E.
Romero-Gomez, M.
机构：
[1] UCM Digest Dis, Madrid, Spain
[2] Hosp Univ Valme, Microbiol Unit, Seville, Spain
[3] Hosp Univ Valme, Biochem Unit, Seville, Spain
来源：
JOURNAL OF HEPATOLOGY | 2007年 / 46卷
关键词：
D O I：
10.1016/S0168-8278(07)62236-3
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
638
引用
收藏
页码：S241 / S241
页数：1
相关论文
共 50 条
  • [21] The Substantial Role of Initial Ribavirin Dose on the Response to Peginterferon α/Ribavirin Therapy in Patients With Genotype 1b Chronic Hepatitis C
    Dai, Chia-Yen
    Huang, Chung-Feng
    Chuang, Wan-Long
    Huang, Jee-Fu
    Yu, Ming-Lung
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (09): : 2358 - 2359
  • [22] Peginterferonα and ribavirin therapy for 24 versus 48 weeks in chronic hepatitis C genotype 1 patients
    Peng, C-Y
    Lai, H-C
    Su, W-P
    Chuang, P-H
    Kao, J-T
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A174 - A175
  • [23] High early virologic response in patients with chronic hepatitis C, genotype 1 treated with peginterferon and ribavirin; The impact of growth factors
    Kugelmas, M
    Semon, WJ
    Spiegelman, G
    Reindollar, R
    JOURNAL OF HEPATOLOGY, 2005, 42 : 208 - 209
  • [24] Peginterferon Lambda-1a/Ribavirin with Daclatasvir or Peginterferon Alfa-2a/Ribavirin with Telaprevir for Chronic Hepatitis C Genotype 1b
    Flisiak, Robert
    Kawazoe, Seiji
    Znoyko, Olga
    Assy, Nimer
    Gadano, Adrian
    Kao, Jia-Horng
    Lee, Kwan-Sik
    Zwirtes, Ricardo
    Portsmouth, Simon
    Dong, Yuping
    Xu, Dong
    Kumada, Hiromitsu
    Srinivasan, Subasree
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2016, 36 (11): : 635 - 643
  • [25] Simeprevir with peginterferon/ribavirin for patients with hepatitis C virus genotype 1: high frequency of viral relapse in elderly patients
    Watanabe, Takao
    Joko, Kouji
    Seike, Hirotaka
    Michitaka, Kojiro
    Horiike, Norio
    Kisaka, Yoshiyasu
    Tanaka, Yoshinori
    Nakanishi, Seiji
    Nakanishi, Kimio
    Nonaka, Takashi
    Yamauchi, Kazuhiko
    Onji, Morikazu
    Ohno, Yoshinori
    Tokumoto, Yoshio
    Hirooka, Masashi
    Abe, Masanori
    Hiasa, Yoichi
    SPRINGERPLUS, 2016, 5
  • [26] Randomized controlled trial of nitazoxanide-peginterferon-ribavirin, nitazoxanide-peginterferon and peginterferon-ribavirin in the treatment of patients with chronic hepatitis C genotype 4
    Rossignol, J. F.
    Elfert, A.
    El-Gohary, Y.
    Keeffe, E. B.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S30 - S30
  • [27] Retreatment with peginterferon and ribavirin in chronic hepatitis C
    Yong Min Jo
    Sung Wook Lee
    Sang Young Han
    Yang Hyun Baek
    Soo Young Kim
    Woo Jae Kim
    Ji Hye Ahn
    Ji Young Lee
    World Journal of Gastroenterology, 2015, (06) : 1994 - 1999
  • [28] Retreatment with peginterferon and ribavirin in chronic hepatitis C
    Jo, Yong Min
    Lee, Sung Wook
    Han, Sang Young
    Baek, Yang Hyun
    Kim, Soo Young
    Kim, Woo Jae
    Ahn, Ji Hye
    Lee, Ji Young
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (06) : 1994 - 1999
  • [29] POPULATION PHARMACOKINETICS (PPK) OF RIBAVIRIN IN PATIENTS WITH CHRONIC HEPATITIS C VIRAL INFECTION GENOTYPE 1
    Jin, Runyan
    Fossler, Michael J.
    Howell, Charles
    Dowling, Thomas
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (09): : 1121 - 1121
  • [30] Insulin Resistance Predicts Rapid Virologic Response to Peginterferon/Ribavirin Combination Therapy in Hepatitis C Genotype 4 Patients
    Khattab, Mahmoud
    Eslam, Mohammed
    Sharwae, Mohammed Ahmed
    Shatat, Mohammed
    Ali, Ahmed
    Hamdy, Lamia
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (09): : 1970 - 1977
12345